Robert Doebele - Feb 3, 2025 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Chief Medical Officer
Signature
/s/ Jessica Oien, Attorney-in- Fact for Robert Doebele.
Stock symbol
BOLD
Transactions as of
Feb 3, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 06:38 PM
Previous filing
Jan 26, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLD Stock Option Award $0 +180K $0.00 180K Feb 3, 2025 Common Stock 180K $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest over a period of four years, with 25% of the shares subject to the option vesting on February 3, 2026, and the remaining shares subject to the option vesting in 36 equal monthly installments thereafter, subject to continued employment or service to the issuer on each such vesting date.